BACKGROUND: The POLG1 gene encodes the catalytic subunit of DNA polymerase gamma, essential for mitochondrial DNA replication and repair. Mutations in POLG1 have been linked to a spectrum of clinical phenotypes, and may account for up to 25% of all adult presentations of mitochondrial disease. METHODS AND RESULTS: We present 14 patients, with characteristic features of mitochondrial disease including progressive external ophthalmoplegia (PEO) and Alpers-Huttenlocher syndrome and laboratory findings indicative of mitochondrial dysfunction, including cytochrome c oxidase (COX) deficiency and multiple deletions or depletion of the mitochondrial DNA. Four novel POLG1 missense substitutions (p.R597W, p.L605R, p.G746S, p.A862T), are described, together with the first adult patient with a recently described polymerase domain mutation (p.R1047W). All novel changes were rare in a control population and affected highly conserved amino acids. CONCLUSION: The addition of these substitutions-including the first report of a dinucleotide mutation (c.1814_1815TT>GC)-to the growing list of defects further confirms the importance of POLG1 mutations as the underlying abnormality in a range of neurological presentations.
BACKGROUND: The POLG1 gene encodes the catalytic subunit of DNA polymerase gamma, essential for mitochondrial DNA replication and repair. Mutations in POLG1 have been linked to a spectrum of clinical phenotypes, and may account for up to 25% of all adult presentations of mitochondrial disease. METHODS AND RESULTS: We present 14 patients, with characteristic features of mitochondrial disease including progressive external ophthalmoplegia (PEO) and Alpers-Huttenlocher syndrome and laboratory findings indicative of mitochondrial dysfunction, including cytochrome c oxidase (COX) deficiency and multiple deletions or depletion of the mitochondrial DNA. Four novel POLG1 missense substitutions (p.R597W, p.L605R, p.G746S, p.A862T), are described, together with the first adult patient with a recently described polymerase domain mutation (p.R1047W). All novel changes were rare in a control population and affected highly conserved amino acids. CONCLUSION: The addition of these substitutions-including the first report of a dinucleotide mutation (c.1814_1815TT>GC)-to the growing list of defects further confirms the importance of POLG1 mutations as the underlying abnormality in a range of neurological presentations.
Authors: Russell P Saneto; Inn-Chi Lee; Mary Kay Koenig; Xinhua Bao; Shao-Wen Weng; Robert K Naviaux; Lee-Jun C Wong Journal: Seizure Date: 2010-02-06 Impact factor: 3.184
Authors: Nichola Z Lax; Roger G Whittaker; Philippa D Hepplewhite; Amy K Reeve; Emma L Blakely; Evelyn Jaros; Paul G Ince; Robert W Taylor; Peter R W Fawcett; Doug M Turnbull Journal: Brain Date: 2011-12-20 Impact factor: 13.501
Authors: Vivienne C M Neeve; David C Samuels; Laurence A Bindoff; Bianca van den Bosch; Gert Van Goethem; Hubert Smeets; Anne Lombès; Claude Jardel; Michio Hirano; Salvatore Dimauro; Maaike De Vries; Jan Smeitink; Bart W Smits; Ireneus F M de Coo; Carsten Saft; Thomas Klopstock; Bianca-Cortina Keiling; Birgit Czermin; Angela Abicht; Hanns Lochmüller; Gavin Hudson; Grainne G Gorman; Doug M Turnbull; Robert W Taylor; Elke Holinski-Feder; Patrick F Chinnery; Rita Horvath Journal: Brain Date: 2012-12 Impact factor: 13.501